SBIR Phase I: In Situ Optical Probe for Real-time Monitoring of Protein Expression Bioreactors

Information

  • NSF Award
  • 1215209
Owner
  • Award Id
    1215209
  • Award Effective Date
    7/1/2012 - 12 years ago
  • Award Expiration Date
    6/30/2013 - 11 years ago
  • Award Amount
    $ 150,000.00
  • Award Instrument
    Standard Grant

SBIR Phase I: In Situ Optical Probe for Real-time Monitoring of Protein Expression Bioreactors

This Small Business Innovation Research Phase I project will develop a fiber optically coupled in situ probe utilizing a superluminescent diode (SLD) optical source for monitoring bioreactor fermentations with ASL?s bioreactor monitor. The current ASL monitor uses a conventional, thermal light source, which is inherently low-brightness and will significantly reduce the instrument?s throughput and SNR when coupled to a limited-aperture fiber. The small emitting area of the SLD, however, is perfectly suited to fiber coupling, and presents a significant advantage in throughput, allowing for accurate measurements in highly turbid solutions. During this effort, SLD devices will be fabricated and coupled to a fiber-optic test assembly. Their analytical performance will be evaluated during live fermentation processes. For a commercial in situ probe that utilizes an SLD to be feasible, it must be capable of obtaining high-quality spectra with an SNR equivalent to or better than the present ASL monitor.<br/><br/>The broader/commercial impacts of this research will both improve the performance of the current ASL bioreactor monitor and enable in situ sampling, which is highly desirable by potential users of this technology. The availability of continuous on-line measurements of key analytes provided by the ASL monitor during protein expression with Pichia pastoris and E. coli supplies a means for active feedback control, aiding in optimization of production yields and helping maintain quality control. Better quality control will reduce labor and production costs and ultimately, reduce the time to market for drug candidates and lower costs to consumers.

  • Program Officer
    Ruth M. Shuman
  • Min Amd Letter Date
    6/5/2012 - 12 years ago
  • Max Amd Letter Date
    10/23/2012 - 12 years ago
  • ARRA Amount

Institutions

  • Name
    ASL Analytical, Inc.
  • City
    Coralville
  • State
    IA
  • Country
    United States
  • Address
    2500 Crosspark Rd., Ste E224
  • Postal Code
    522414710
  • Phone Number
    3196652214

Investigators

  • First Name
    Elizabeth
  • Last Name
    Gibson
  • Email Address
    egibson@asl-analytical.com
  • Start Date
    6/5/2012 12:00:00 AM